TEOC Oncologia Clínica common mistakes
TEOC Oncologia Clínica · Understand the traps and how to avoid them.
Choosing the answer that lists every systemic option for a patient whose cancer is potentially curable with local therapy, instead of committing to the single curative-intent treatment.
Candidates pattern-match to 'advanced cancer' templates and are anxious about missing an option, so they pick the most inclusive answer rather than the one that matches disease stage and intent.
What to do instead
Before reading the options, write one word on the scratchpad: curative or palliative. Then eliminate any option inconsistent with that intent before comparing the remaining choices on efficacy and toxicity.
Staging with the older edition of the TNM classification or applying a staging system from a different tumour type.
Study material from prior years is reused and the edition in force is not checked, and candidates rely on memory of a familiar schema rather than verifying which system applies to that organ.
What to do instead
At the start of each study block, state aloud the current edition in force and the specific staging system for that tumour (for example a separate system for hepatocellular carcinoma or for haematological malignancies), and practise restating stage definitions from that source only.
Selecting a regimen without adjusting for organ function, performance status, or frailty, giving a fit-patient dose to an older or renally impaired patient.
Regimen memorisation is done as a list of drug names, so dose modification rules and fitness assessment are never encoded as part of the regimen.
What to do instead
Learn every regimen as a triple: indication and line of therapy, fitness prerequisite, and dose adjustment rule. When answering, first classify the patient's performance status and organ function, then choose the regimen that the classification permits.
Confusing adjuvant with neoadjuvant intent, and therefore misjudging whether surgery or systemic therapy comes first and what the endpoint of treatment is.
Both settings use the same drugs, so candidates retrieve the drug name and stop, without retrieving the sequence and purpose attached to it.
What to do instead
For each commonly tested regimen, write a one-line timeline (for example surgery then systemic therapy, or systemic therapy then surgery then systemic therapy) and the endpoint each setting pursues. Answer sequence questions from the timeline, not from the drug name.
Treating a tumour marker elevation as diagnostic of recurrence or of a new primary without interpreting it against the clinical context and the assay's limitations.
Markers are taught as numbers with cut-offs, so candidates apply the cut-off mechanically and ignore false positives from inflammation, benign disease, or assay interference.
What to do instead
For every marker, memorise three things: the settings in which it is useful for monitoring, the common benign causes of elevation, and the confirmatory step required before acting. Rehearse the confirmatory step as part of the answer.
Managing a suspected oncological emergency (febrile neutropenia, spinal cord compression, tumour lysis syndrome, superior vena cava obstruction, hypercalcaemia) with the definitive anticancer plan instead of the immediate stabilising intervention.
The question stem contains a cancer diagnosis, which pulls attention toward oncology treatment, while the actual question asks for the next immediate action.
What to do instead
Drill emergencies as fixed action sequences with time frames, and practise identifying the question word (next step, most urgent, definitive) before reading the options. If the stem describes an emergency, answer the stabilising step first.
Attributing treatment toxicity to the wrong drug or missing the toxicity that requires permanent discontinuation rather than dose reduction.
Toxicity profiles are studied as loose associations rather than as decision rules, so candidates recognise that a drug causes a side effect but not what to do about it.
What to do instead
Build a table with one row per drug class and columns for characteristic toxicity, monitoring test, and action (continue, reduce, hold, stop permanently). Test yourself by working from toxicity back to drug and to action.
Overlooking drug interactions and supportive-care prophylaxis, such as omitting antiemetic or growth-factor prophylaxis or missing an interaction with a co-prescribed medication.
Supportive care is treated as background knowledge and is not revised with the same rigour as cytotoxic regimens, so it is not retrieved under time pressure.
What to do instead
Attach a supportive-care bundle to every regimen you learn: emetogenicity and antiemetic tier, growth-factor indication, interaction warnings, and prophylaxis for infection or organ toxicity. Answer questions by reciting the bundle before choosing.
Reading only the last line of a long vignette and answering a question that was not asked, or ignoring a decisive detail buried in the history.
Time pressure encourages skimming, and long stems reward the habit of jumping to the question, which then gets answered out of context.
What to do instead
Use a fixed reading order: final question first, then the last two sentences of the history, then a full read to capture age, performance status, prior therapy, and comorbidities. Mark the decisive detail before evaluating options.
Changing a correct first answer on review because a distractor feels familiar, without identifying a concrete factual reason for the change.
Recognition memory favours familiar wording, so a plausible distractor can feel more correct than the reasoned answer, and anxiety drives second-guessing.
What to do instead
Adopt a rule that an answer is changed only when a specific fact can be named that invalidates the original reasoning. Log every changed answer with the reason, and review the log to calibrate how often changes help.